4-Sep-2026
Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference
Globe Newswire (Thu, 3-Sep 4:15 PM ET)
PRNewswire (Wed, 19-Aug 8:30 AM ET)
Dentsply Sirona Reports Second Quarter 2026 Results
Globe Newswire (Thu, 6-Aug 4:01 PM ET)
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Wed, 29-Jul 9:13 AM ET)
Globe Newswire (Tue, 28-Jul 8:30 AM ET)
Dentsply Sirona to Host Second Quarter Conference Call on August 6th
Globe Newswire (Tue, 21-Jul 4:15 PM ET)
Globe Newswire (Wed, 1-Jul 5:00 PM ET)
XRAY Appoints John Fortson as CFO: Leadership Experience Signals Focus on Growth and Efficiency
Market Chameleon (Fri, 12-Jun 7:46 AM ET)
Dentsply Sirona Appoints John Fortson as Chief Financial Officer
Globe Newswire (Thu, 11-Jun 8:30 AM ET)
Dentsply Sirona’s Upcoming Conference Appearance Highlights Strategic Position in Dental Technology
Market Chameleon (Wed, 4-Mar 2:33 AM ET)
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.
Dentsply Sirona trades on the NASDAQ stock market under the symbol XRAY.
As of September 4, 2026, XRAY stock price declined to $11.38 with 2,409,720 million shares trading.
XRAY has a beta of 0.99, meaning it tends to be less sensitive to market movements. XRAY has a correlation of 0.06 to the broad based SPY ETF.
XRAY has a market cap of $2.28 billion. This is considered a Mid Cap stock.
Last quarter Dentsply Sirona reported $898 million in Revenue and $.52 earnings per share. This beat revenue expectation by $11 million and exceeded earnings estimates by $.17.
In the last 3 years, XRAY traded as high as $37.60 and as low as $9.41.
The top ETF exchange traded funds that XRAY belongs to (by Net Assets): VTI, IJH, VB, VBR, VXF.
XRAY has underperformed the market in the last year with a return of -18.4%, while SPY returned +19.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in XRAY shares. However, XRAY has outperformed the market in the last 3 month and 2 week periods, returning +15.2% and +4.2%, while SPY returned +2.0% and +0.6%, respectively. This indicates XRAY has been having a stronger performance recently.
XRAY support price is $11.10 and resistance is $11.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XRAY shares will trade within this expected range on the day.